This session from the 2020 Midyear Clinical Meeting, planned in cooperation with the ASHP Section of Clinical Specialists and Scientists, features a review of recent updates to the ADHD treatment guidelines and compares and contrasts newer formulations of ADHD medications.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.